These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8540540)

  • 1. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
    Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R
    Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC
    Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
    Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
    Dastych M; Procházková D; Pokorný A; Zdrazil L
    Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Wilson's disease].
    Hoogenraad TU; van Hattum J
    Dtsch Med Wochenschr; 1987 Jun; 112(23):942-3. PubMed ID: 3582206
    [No Abstract]   [Full Text] [Related]  

  • 6. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
    Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful long term oral zinc in florid Wilson's disease: a case report.
    Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
    Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years].
    Alexiou D; Hatzis T; Koutselinis A
    Arch Fr Pediatr; 1985; 42(6):447-9. PubMed ID: 4051676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Wilson's disease with zinc. IX: Response of serum lipids.
    Brewer GJ; Yuzbasiyan-Gurkan V; Johnson V
    J Lab Clin Med; 1991 Nov; 118(5):466-70. PubMed ID: 1940587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease.
    Yuzbasiyan-Gurkan V; Brewer GJ; Abrams GD; Main B; Giacherio D
    J Lab Clin Med; 1989 Nov; 114(5):520-6. PubMed ID: 2478644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K; Siegemund R; Lössner J; Kühn HJ
    Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic approaches to Wilson's disease].
    Meiner Z
    Harefuah; 1990 Mar; 118(5):296-8. PubMed ID: 2344986
    [No Abstract]   [Full Text] [Related]  

  • 19. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.